Prevalence of HIV, HCV and HBV in IDUs
Tables INF1, INF2 and INF3 provide a summary overview of latest available data on HIV, HCV and HBV prevalence in samples of injecting drug users.
Tables INF108, INF109 and INF110 show full data on HIV prevalence in samples of injecting drug users, as well as prevalence among young injectors and new injectors for HIV (see also Figure INF3).
Tables INF111, INF112 and INF113 show full data on HCV prevalence in samples of injecting drug users as well as prevalence among young injectors and new injectors for HCV (see also Figure INF6).
Table INF114 and Table INF115 show full data on prevalence of HBV current infection (HBsAg) and of HBV antibodies (aHBc, aHBs), respectively (see also Figure INF9).
Table INF117 shows prevalence of HIV, HCV and HBV markers among (injecting) drug users in prison. Part (i) shows prevalence of HIV infection, part (ii) of hepatitis C antibodies, part (iii) of HBsAg, a marker of current hepatitis B infection, and part (iv) of hepatitis B antibodies.
HIV case reporting and hepatitis B/C notifications
Tables INF104 show HIV case reporting data. These data, provided by ECDC–WHO/Europe, are both provided as case counts and as rates per million population (see also Figure INF1 and Figure INF2).
Tables INF105 and INF106 show notifications of newly diagnosed HCV and HBV cases, respectively. For hepatitis notifications, rates per million are not calculated, given the likely low comparability of the data between countries. These tables also give the percentage of IDUs among the cases of hepatitis C and B that have information on the presumed transmission category.
Table INF107: a small number of countries report incidence data for HCV from followup studies of IDUs at mostly subnational level. Table INF107 reports the number of IDUs followed, the number of seroconversions, followup time, the incidence rate per 100 personyears.
Table INF0 lists all bibliographic references.
The table below summarises the overall organisation of the core set of tables and graphs.

HIV/AIDS 
Hepatitis C 
Hepatitis B 
Prevalence — latest data overview 

Prevalence — full data and time trends 

Prevalence — full data and time trends in young and new IDUs 
~ 

Case reports/notifications 